TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection

NACompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Tuberculosis
Interventions
DRUG

Rifapentine + isoniazid once weekly for 3 months

Trial Locations (24)

10032

Columbia University, New York

20422

Washington DC Veterans Administration Medical Center, Washington D.C.

21231

Northwestern University School of Medicine, Chicago

Johns Hopkins University School of Medicine, Baltimore

27710

Duke University Medical Center, Durham

30303

Emory University School of Medicine, Atlanta

37232

Veterans Administration Tennessee Valley Health Care System, Nashville

60141

Hines Veterans Administration Medical Center, Hines

72205

Central Arkansas Veterans Health System, Little Rock

76104

University of North Texas Health Science Center, Fort Worth

77030

Houston Veterans Administration Medical Center, Houston

78284

Audie L. Murphy VA Hospital, San Antonio

80204

Denver Public Health Department, Denver

90033

University of Southern California Medical Center, Los Angeles

92103

University of California at San Diego, San Diego

94110

University of California, San Francisco, San Francisco

98104

Seattle-King County Health Department, Seattle

02118

Boston University Medical Center, Boston

07103

New Jersey School of Medicine, Newark

2194.590

Hopital Universitario Clementino Fraga Filho, Rio de Janeiro

V5Z 4R4

University of British Columbia, Vancouver

R3A 1R8

University of Manitoba, Winnepeg

H2X 2P4

Montreal Chest Institute, Montreal

080023

Agencia de Salut Publica, Barcelona

All Listed Sponsors
collaborator

US Department of Veterans Affairs

FED

lead

Centers for Disease Control and Prevention

FED

NCT00164450 - TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection | Biotech Hunter | Biotech Hunter